95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.19%
Revenue growth under 50% of FSM's 17.09%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
9.00%
Gross profit growth at 50-75% of FSM's 17.25%. Martin Whitman would question if cost structure or brand is lagging.
6.22%
EBIT growth 50-75% of FSM's 9.77%. Martin Whitman would suspect suboptimal resource allocation.
6.22%
Operating income growth at 50-75% of FSM's 9.77%. Martin Whitman would doubt the firm’s ability to compete efficiently.
-25.44%
Negative net income growth while FSM stands at 54.78%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-25.00%
Negative EPS growth while FSM is at 52.40%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-25.00%
Negative diluted EPS growth while FSM is at 53.30%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.07%
Slight or no buybacks while FSM is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.10%
Diluted share reduction more than 1.5x FSM's 2.84%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
6.73%
OCF growth under 50% of FSM's 50.52%. Michael Burry might suspect questionable revenue recognition or rising costs.
176.60%
FCF growth 75-90% of FSM's 204.01%. Bill Ackman might push for improved capital allocation or operational changes to match the competitor.
58.74%
10Y revenue/share CAGR under 50% of FSM's 144.33%. Michael Burry would suspect a lasting competitive disadvantage.
55.15%
5Y revenue/share CAGR at 50-75% of FSM's 102.24%. Martin Whitman would worry about a lagging mid-term growth trajectory.
-10.17%
Negative 3Y CAGR while FSM stands at 31.78%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
79.88%
10Y OCF/share CAGR under 50% of FSM's 346.72%. Michael Burry would worry about a persistent underperformance in cash creation.
110.42%
5Y OCF/share CAGR above 1.5x FSM's 60.03%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
7.26%
3Y OCF/share CAGR under 50% of FSM's 50.29%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
51.96%
Below 50% of FSM's 484.79%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
196.44%
5Y net income/share CAGR above 1.5x FSM's 106.95%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-26.91%
Negative 3Y CAGR while FSM is 52.02%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
61.34%
10Y equity/share CAGR at 50-75% of FSM's 112.63%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
37.69%
5Y equity/share CAGR above 1.5x FSM's 13.28%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
19.58%
3Y equity/share CAGR above 1.5x FSM's 4.88%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
144.99%
Dividend/share CAGR of 144.99% while FSM is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
115.34%
Dividend/share CAGR of 115.34% while FSM is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
33.37%
3Y dividend/share CAGR of 33.37% while FSM is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
80.90%
Our AR growth while FSM is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-8195400.00%
Inventory is declining while FSM stands at 4.50%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.97%
Asset growth well under 50% of FSM's 4.07%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
1.18%
Under 50% of FSM's 6.09%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-3.35%
We’re deleveraging while FSM stands at 1.34%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
42.05%
SG&A growth well above FSM's 19.84%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.